700 patients110,866 observations180 daysLIVE

Patient P-02054

Synthetic patientMETA-24 · Day 171 · 65–74 · F · baseline S01Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Stable
GI state
Deteriorating
Inflammatory state
Stable
Nutritional resilience
Declining
Discontinuation risk
49%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S01
  2. Day 119 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 122 CR-01 recommendedClinician Review CR-01
  4. Day 123 Patient acceptedStarted CR-01 in the companion
  5. Day 128 Deterioration detected before clinical escalationClinician Review CR-01

What changed?

Trajectory began diverging from predicted response on Day 119.

Primary contributors, last 14 days
  • Nutritional resilience-8
  • GI instability+4
  • Inflammatory activity+3
  • Treatment adherence-2

What helped?

  • Clinician Review CR-01Day 122
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
57%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 89% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
60 min
stable · +0.6 vs previous 14 d
Sleep duration
Wearable
7 h
stable · +0.2 vs previous 14 d
Energy level
Daily log
3.3/10
improving · +0.3 vs previous 14 d
Steps
Wearable
6,216
stable · +32 vs previous 14 d
GI burden
Companion
43.4/100
improving · -2.9 vs previous 14 d
Adherence
Companion
74.4 %
worsening · -5.0 vs previous 14 d
Sleep quality
Wearable
43.1/100
improving · +2.8 vs previous 14 d
Glucose, CGM daily mean
CGM
137 mg/dL
stable · +1.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 44 from the failing basin, 44 from restoration.

Would help
  • GI-04 GI Support Protocol
    77% improved among 64 similar · onset 8 d · confidence 51%
  • ME-01 Monitoring Escalation
    100% improved among 42 similar · onset 3 d · confidence 59%
  • NP-02 Dietary Support Protocol
    59% improved among 32 similar · onset 10 d · confidence 59%
  • More protein
    GI -5.1 next day on high-intake days · n 16
Would not help
  • Keep simple carbs low
    GI +3.6 next day on high-intake days · n 15
  • Keep alcohol low
    GI +3.6 next day on high-intake days · n 23
  • Keep ultra-processed low
    GI +3.1 next day on high-intake days · n 15
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.1supporter · 95%
  • Simple carbohydrates
    +3.6detractor · 95%
  • Alcohol
    +3.6detractor · 95%
  • Ultra-processed food
    +3.1detractor · 95%
  • Histamine load
    +1.1no signal · 32%
  • Insoluble fibre
    +0.9no signal · 23%
  • Caffeine
    -0.7no signal · 16%
  • Dietary fat load
    +0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 45
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 52
  • Autonomic recovery 25
    • WearableResting HR 77 bpm
  • Butyrate / short-chain fatty acid production 20
    • Daily logFibre intake low in recent food logs
  • Drug metabolism and exposure 20
    • BloodToxicity index 49
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.3 · butyrate capacity 48/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
43 ms
Sleep
7.0 h
Steps
5,633
Resting HR
79 bpm
Daily log: GI score 43, nutritional resilience 43, adherence 74.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0239848%S06GI-04improved63
P-0200943%S08CR-01improved64
P-0223342%S16CR-01improved66
P-0202541%S15CR-01improved61
P-0215141%S04CR-01improved49
P-0224041%S20GI-04improved57
P-0243341%S07GI-04improved61
P-0215440%S16CR-01improved57
P-0232140%S17GI-04improved54
P-0233440%S04GI-04improved66
P-0241037%S01GI-04improved55
P-0267437%S02NP-02improved48